Anna Czlonkowska
chairman
management
Wilson Therapeutics
Sweden
Biography
Education and other assignments: Anna Czlonkowska, MD, Prof, earned her Diploma of Medicine at Warsaw Medical Academy before she completed her Doctor of Medicine at the Institute of Psychiatry and Neurology, Warsaw. She received additional training at the Boards of Clinical Neurology at the Institute of Psychiatry and Neurology in Warsaw and Habilitation in Neurology at the Warsaw Medical Academy. She has also received several fellowships, ranging from the British Council Grant for Neuroimmunology and the Neurobiology Fellow via Max Planck Society Grant. Between 1985-2013, she served as a professor and the Head of the Second Department of Neurology and is currently the professor in this department and the Head of the Study Group at the Department of Experimental and Clinical Pharmacology, Medical University of Warsaw. Additionally, Czlonkowska served as a member of the International Consortium at EUROWILSON. Since 1969, Czlonkowska has cared for 800 patients with Wilson Disease and established a database. She cooperates with WD centers across Europe and has evaluated the clinical course of WD (with a focus on the efficacy of current therapies). She has also completed basic research for the evaluation of pathogenesis of WD.
Research Interest
ompleted basic research for the evaluation of pathogenesis of WD.